Viral Inactivation Market
Viral Inactivation Market Size, Share, Trends, Growth and Forecasts, 2019–2025
Viral inactivation is one of the processes used for viral processing, in which the viruses remain in the final product in an inactive form. It differs from viral removal process as in viral removal process, viruses are removed from the final product completely. Virus inactivation process is critical in process development for biologicals such as tissue and tissue products, stem cell products, cellular and gene therapy products, blood and blood products, and vaccines and therapeutics. Moreover, the process of viral inactivation has been made necessary by regulatory authorities, such as the US Food and Drug Association (FDA) for investigational new drug (IND) submission. Thereby, contributing towards the growth of the global viral inactivation market. Additionally, rapid growth in pharmaceutical and biotechnology industries coupled with extensive R&D investments in the life sciences sector is further propelling the market growth.
Global viral inactivation market has been analyzed, on the basis of regions, into North America, Europe, Asia-Pacific, and Rest of the World. These regions are contributing significantly towards market growth. North America held the largest market share in 2018 and is continuing to do so over the forecast period. Factors augmenting the growth of North American viral inactivation market include well-developed healthcare infrastructure, presence of key pharmaceutical and biopharmaceutical companies, and significant healthcare R&D expenditure by government and companies. However, Asia-Pacific is expected to grow at the fastest rate over the forecast period. Rapidly evolving healthcare infrastructure across the region and increasing prevalence of chronic diseases in emerging economies such as India and China are augmenting the Asia-Pacific viral inactivation market growth.
Furthermore, the market consists of several players that are providing reagents & kits, systems, and services for viral inactivation process to cater to a wide range of end-users. Some of the market players of viral inactivation market include Danaher Corp., Merck KGaA, Sartorius AG, Parker Hannifin Corp., and General Electric Co. These players adopt various strategies; such as mergers and acquisitions, product launch, geographical expansion, and partnerships and collaborations; in order to remain competitive in the market. For instance, Pall Corp., a subsidiary of Danaher Corp., launched the Cadence Virus Inactivation system in September 2017. The system provides the ability to perform low pH virus inactivation to an incoming elution stream continuously.
Research Methodology:
The market study of the global viral inactivation market is incorporated by extensive primary and secondary research conducted by a research team at OMR. Secondary research has been conducted to refine the available data to break down the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macroeconomic factors. Numbers extracted from Secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings the authenticity of our reports.
Secondary Sources Include:
- Financial reports of companies involved in the market
- Whitepapers, research-papers and news blogs
- Company websites and their product catalog
The report is intended for market research firms, investment companies, pharmaceutical & biopharmaceutical companies, research institutes for overall market analysis and competitive analysis. The report will serve as a source for 360-degree analysis of the market thoroughly integrating different models delivering insights into the market for better business decisions.
Market Segmentation:
- Global Viral Inactivation Market Research and Analysis by Product Type
- Global Viral Inactivation Market Research and Analysis by Application
- Global Viral Inactivation Market Research and Analysis by End-User
The Report Covers:
- Comprehensive research methodology of the global viral inactivation
- This report also includes a detailed and extensive market overview with key analyst insights.
- An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
- Analysis of regional regulations and other government policies impacting the global viral inactivation market.
- Insights about market determinants which are stimulating the global viral inactivation
- Detailed and extensive market segments with regional distribution of forecast revenues.
- Extensive profiles and recent developments of market players.
1. Report Summary
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
1.2.2. By Geography
1.2.3. By Stakeholders
2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
2.3. Rules & Regulations
3. Competitive Landscape
3.1. Competitive Dashboard
3.2. Key Strategy Analysis
3.3. Key Company Analysis
3.3.1. Danaher Corp.
3.3.1.1. Overview
3.3.1.2. Financial Analysis
3.3.1.3. Swot Analysis
3.3.1.4. Recent Developments
3.3.2. Merck KGaA
3.3.2.1. Overview
3.3.2.2. Financial Analysis
3.3.2.3. Swot Analysis
3.3.2.4. Recent Developments
3.3.3. Sartorius AG
3.3.3.1. Overview
3.3.3.2. Financial Analysis
3.3.3.3. Swot Analysis
3.3.3.4. Recent Developments
3.3.4. Parker Hannifin Corp.
3.3.4.1. Overview
3.3.4.2. Financial Analysis
3.3.4.3. Swot Analysis
3.3.4.4. Recent Developments
3.3.5. General Electric Co.
3.3.5.1. Overview
3.3.5.2. Financial Analysis
3.3.5.3. Swot Analysis
3.3.5.4. Recent Developments
4. Market Determinants
4.1. Motivators
4.2. Restraints
4.3. Opportunities
5. Market Segmentation
5.1. Global Viral Inactivation Market by Product Type
5.1.1. Kits & Reagents
5.1.2. Systems
5.1.3. Services
5.2. Global Viral Inactivation Market by Application
5.2.1. Vaccines and Therapeutics
5.2.2. Blood and Blood Products
5.2.3. Stem Cell Products
5.2.4. Tissue and Tissue Products
5.2.5. Others (Cellular and Gene Therapy Products)
5.3. Global Viral Inactivation Market by End-User
5.3.1. Pharmaceutical and Biopharmaceutical Companies
5.3.2. Contract Research Organizations
5.3.3. Others (Research Institutes)
6. Regional Analysis
6.1. North America
6.1.1. United States
6.1.2. Canada
6.2. Europe
6.2.1. UK
6.2.2. Germany
6.2.3. Italy
6.2.4. Spain
6.2.5. France
6.2.6. Rest of Europe
6.3. Asia-Pacific
6.3.1. China
6.3.2. India
6.3.3. Japan
6.3.4. Rest of Asia-Pacific
6.4. Rest of the World
7. Company Profiles
7.1. Charles River Laboratories International, Inc.
7.2. Danaher Corp.
7.3. General Electric Co.
7.4. GlaxoSmithKline PLC
7.5. Invitrogen Corp.
7.6. Merck KGaA
7.7. MockV Solutions
7.8. Parker Hannifin Corp.
7.9. Qiagen NV
7.10. Rad Source Technologies, Inc.
7.11. Sanofi SA
7.12. Sartorius AG
7.13. Texcell, Inc.
7.14. Viral Inactivated Plasma Systems SA
7.15. Vironova AB
7.16. Wuxi Pharmatech (Cayman) Inc.
7.17. ZeptoMetrix Corp.
1. GLOBAL VIRAL INACTIVATION MARKET RESEARCH AND ANALYSIS BY PRODUCT TYPE, 2018-2025 ($ MILLION)
2. GLOBAL KITS & REAGENTS FOR VIRAL INACTIVATION MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
3. GLOBAL SYSTEMS FOR VIRAL INACTIVATION MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
4. GLOBAL SERVICES FOR VIRAL INACTIVATION MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
5. GLOBAL VIRAL INACTIVATION MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2018-2025 ($ MILLION)
6. GLOBAL VIRAL INACTIVATION IN VACCINES AND THERAPEUTICS MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
7. GLOBAL VIRAL INACTIVATION IN BLOOD AND BLOOD PRODUCTS MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
8. GLOBAL VIRAL INACTIVATION IN STEM CELL PRODUCTS MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
9. GLOBAL VIRAL INACTIVATION IN TISSUE AND TISSUE PRODUCTS MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
10. GLOBAL VIRAL INACTIVATION IN OTHER APPLICATIONS MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
11. GLOBAL VIRAL INACTIVATION MARKET RESEARCH AND ANALYSIS BY END-USER, 2018-2025 ($ MILLION)
12. GLOBAL VIRAL INACTIVATION IN PHARMACEUTICAL AND BIOPHARMACEUTICAL
COMPANIES MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
13. GLOBAL VIRAL INACTIVATION IN CRO MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
14. GLOBAL VIRAL INACTIVATION IN OTHER END-USERS MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
15. GLOBAL VIRAL INACTIVATION MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2018-2025 ($ MILLION)
16. NORTH AMERICAN VIRAL INACTIVATION MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2018-2025 ($ MILLION)
17. NORTH AMERICAN VIRAL INACTIVATION MARKET RESEARCH AND ANALYSIS BY PRODUCT TYPE, 2018-2025 ($ MILLION)
18. NORTH AMERICAN VIRAL INACTIVATION MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2018-2025 ($ MILLION)
19. NORTH AMERICAN VIRAL INACTIVATION MARKET RESEARCH AND ANALYSIS BY END-USER, 2018-2025 ($ MILLION)
20. EUROPEAN VIRAL INACTIVATION MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2018-2025 ($ MILLION)
21. EUROPEAN VIRAL INACTIVATION MARKET RESEARCH AND ANALYSIS BY PRODUCT TYPE, 2018-2025 ($ MILLION)
22. EUROPEAN VIRAL INACTIVATION MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2018-2025 ($ MILLION)
23. EUROPEAN VIRAL INACTIVATION MARKET RESEARCH AND ANALYSIS BY END-USER, 2018-2025 ($ MILLION)
24. ASIA-PACIFIC VIRAL INACTIVATION MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2018-2025 ($ MILLION)
25. ASIA-PACIFIC VIRAL INACTIVATION MARKET RESEARCH AND ANALYSIS BY PRODUCT TYPE, 2018-2025 ($ MILLION)
26. ASIA-PACIFIC VIRAL INACTIVATION MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2018-2025 ($ MILLION)
27. ASIA-PACIFIC VIRAL INACTIVATION MARKET RESEARCH AND ANALYSIS BY END-USER, 2018-2025 ($ MILLION)
28. REST OF THE WORLD VIRAL INACTIVATION MARKET RESEARCH AND ANALYSIS BY PRODUCT TYPE, 2018-2025 ($ MILLION)
29. REST OF THE WORLD VIRAL INACTIVATION MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2018-2025 ($ MILLION)
30. REST OF THE WORLD VIRAL INACTIVATION MARKET RESEARCH AND ANALYSIS BY END-USER, 2018-2025 ($ MILLION)
1. GLOBAL VIRAL INACTIVATION MARKET SHARE BY PRODUCT TYPE, 2018 VS 2025 (%)
2. GLOBAL VIRAL INACTIVATION MARKET SHARE BY APPLICATION, 2018 VS 2025 (%)
3. GLOBAL VIRAL INACTIVATION MARKET SHARE BY END-USER, 2018 VS 2025 (%)
4. GLOBAL VIRAL INACTIVATION MARKET SHARE BY GEOGRAPHY, 2018 VS 2025 (%)
5. US VIRAL INACTIVATION MARKET SIZE, 2018-2025 ($ MILLION)
6. CANADA VIRAL INACTIVATION MARKET SIZE, 2018-2025 ($ MILLION)
7. UK VIRAL INACTIVATION MARKET SIZE, 2018-2025 ($ MILLION)
8. FRANCE VIRAL INACTIVATION MARKET SIZE, 2018-2025 ($ MILLION)
9. GERMANY VIRAL INACTIVATION MARKET SIZE, 2018-2025 ($ MILLION)
10. ITALY VIRAL INACTIVATION MARKET SIZE, 2018-2025 ($ MILLION)
11. SPAIN VIRAL INACTIVATION MARKET SIZE, 2018-2025 ($ MILLION)
12. ROE VIRAL INACTIVATION MARKET SIZE, 2018-2025 ($ MILLION)
13. INDIA VIRAL INACTIVATION MARKET SIZE, 2018-2025 ($ MILLION)
14. CHINA VIRAL INACTIVATION MARKET SIZE, 2018-2025 ($ MILLION)
15. JAPAN VIRAL INACTIVATION MARKET SIZE, 2018-2025 ($ MILLION)
16. REST OF ASIA-PACIFIC VIRAL INACTIVATION MARKET SIZE, 2018-2025 ($ MILLION)
17. REST OF THE WORLD VIRAL INACTIVATION MARKET SIZE, 2018-2025 ($ MILLION)
